In CLL cells gene expression profiling detected high levels of the glioma associated oncogene-1 (GLI1) and GLI1 levels correlated with disease progression and unfavorable clinical outcome [13]. This evidence concerns the gene GLI1 and B-cell chronic lymphocytic leukemia.